Opening: Real Consultation Scenario
📋 Real Consultation Scenario
A 38-year-old woman, AMH 1.2 ng/mL, previously had one egg retrieval yielding 4 eggs, with no transferable embryos formed. She asked in the clinic: “I’ve researched the US, Japan, Thailand, and Russia, but every clinic describes a different process. Which country is truly more suitable for my situation? What are the differences in the process? How much time do I need to prepare?”
This question is not simply “which country is better,” but requires breaking down the substantive differences in each country’s process based on age, ovarian reserve, genetic risk, and budget.
Overseas IVF Process Comparison: Where Are the Core Differences?
The differences in overseas IVF processes essentially center on four dimensions: ovarian stimulation protocol logic, embryo culture strategy, legal restrictions on genetic screening (PGT), and the time density of the cycle. The choices different countries make in these four dimensions determine the length, complexity, and cost structure of the entire process from initial consultation to the end of transfer.
From a process structure perspective, IVF in all countries includes: initial consultation and filing → ovarian stimulation → egg retrieval → embryo culture → transfer → luteal phase support. However, the specific operations and standards at each stage vary significantly.
👨⚕️ Practitioner Observation (10-year industry consultant): Many patients think “the process is the same, just a different location.” In reality, the process designs in the US, Japan, Thailand, and Russia are based on different population fertility characteristics and medical regulatory logics. The US aims for “maximum egg yield per cycle,” Japan focuses on “mild stimulation, multiple accumulations,” while Thailand and Russia follow a “standardized, high-efficiency” route. There is no absolute superiority, only suitability.
Comparison of Core Parameters for IVF Processes in Four Countries
| Process Dimension | 🇺🇸 United States | 🇯🇵 Japan | 🇹🇭 Thailand | 🇷🇺 Russia |
|---|---|---|---|---|
| Typical Cycle Length | 6–10 weeks (including PGT) | 4–12 weeks (depending on protocol) | 4–6 weeks | 4–8 weeks |
| Mainstream Ovarian Stimulation Protocol | Antagonist / Long protocol, high dose | Mild stimulation / Natural cycle / Low dose | Antagonist primarily, moderate dose | Antagonist / Short protocol, flexible dosing |
| Embryo Culture Strategy | Routine blastocyst culture + PGT-A/PGT-M | Cleavage stage or blastocyst, PGT less common | Blastocyst culture + PGT-A (optional) | Blastocyst culture + PGT-A (optional) |
| Legal Restrictions on PGT | No restrictions, sex selection allowed (some states) | PGT limited to serious genetic diseases, sex selection prohibited | PGT allowed, sex selection prohibited | PGT allowed, sex selection prohibited |
| Egg Retrieval Method | IV sedation / General anesthesia | IV sedation | IV sedation / General anesthesia | IV sedation / General anesthesia |
| Transfer Strategy | Primarily single blastocyst transfer | Single cleavage stage or blastocyst transfer | Primarily single blastocyst transfer | Primarily single blastocyst transfer |
| Total Cost Reference (USD) | $25,000–$45,000+ | $12,000–$22,000 | $9,000–$15,000 | $7,000–$14,000 |
Detailed Breakdown of IVF Processes by Country
🇺🇸 United States Process: High Density, High Screening, High Freedom
The design goal of the US process is to maximize the live birth rate within a single complete cycle, thus favoring high-dose stimulation, mandatory or recommended PGT-A screening, and strict embryo quality selection. The process is roughly as follows:
- Initial Consultation (Week 1–2): Remote or in-clinic, complete AMH, FSH, LH, E2, antral follicle count (AFC), semen analysis, infectious disease screening, chromosome karyotype analysis. Some clinics require hysteroscopy or endometrial microbiome testing.
- Filing and Legal Documents (Week 2–3): Sign informed consent, embryo disposition agreement, genetic screening consent. Passport validity must cover the entire cycle; some states require additional notarization.
- Ovarian Stimulation (Week 4–7): Start on cycle day 2–3, using FSH/HMG combined with antagonist, average stimulation 10–14 days. High monitoring frequency (approximately 4–6 ultrasounds + hormone tests).
- Egg Retrieval (Week 7): General anesthesia or IV sedation, about 15–30 minutes. Post-operative observation for 1–2 hours.
- Embryo Culture and PGT (Week 7–11): Culture to blastocyst after fertilization (day 5–6), biopsy of trophectoderm cells, send for PGT-A/PGT-M, wait for report approximately 10–14 days.
- Transfer (Week 8–12): Natural cycle or artificial cycle for endometrial preparation, transfer single blastocyst, blood test for hCG 9–12 days after transfer.
🔍 Easiest Detail to Overlook: US clinics have strict requirements for male semen analysis, some require 2–3 days of abstinence and must include DNA fragmentation index (DFI) testing. If DFI > 15%, they may recommend semen processing or ICSI. Additionally, US clinics typically require female AMH > 0.5 to accept autologous egg cycles; below this value, they will directly recommend egg donation.
🇯🇵 Japan Process: Mild Stimulation, Low Dose, Multiple Accumulations
The core logic of the Japanese process is “quality through quantity of cycles,” particularly suitable for patients with low ovarian reserve (AMH < 1.5) or advanced age (>40 years). The process features low-dose stimulation, low cycle risk, but may require multiple egg retrievals to accumulate enough embryos.
- Initial Consultation (Week 1): Basic hormone testing + AFC + semen analysis. Japanese clinics generally emphasize AMH and vitamin D levels, routinely supplementing CoQ10 and DHEA (as appropriate).
- Filing: Requires passport, residence card (if applicable), marriage certificate (some clinics). Process is relatively simple.
- Ovarian Stimulation (Week 2–5): Clomiphene + low-dose FSH, or letrozole + low-dose HMG, stimulation cycle typically 6–9 days. Lower monitoring frequency, about 3–4 times.
- Egg Retrieval (Week 5): IV sedation, short retrieval time, can leave after 2 hours of observation.
- Embryo Culture (Week 5–7): Mostly cultured to cleavage stage (day 3) or blastocyst (day 5), PGT use is less common, only in cases of recurrent miscarriage or clear genetic history.
- Transfer (Week 6–8): Fresh or frozen embryo transfer. Japanese doctors tend to use natural cycles or hormone replacement cycles, with lower intensity luteal phase support.
🔍 Common Pitfall: Japanese clinics have different “embryo grading” standards compared to Europe and the US. Some clinics are conservative in grading day 3 embryos and may suggest discarding embryos they consider “unqualified,” but these embryos might still be transferable in Thailand or the US. It is advisable to confirm the embryo grading standards before starting the cycle.
🇹🇭 Thailand Process: Standardized, High Efficiency, Outstanding Value
The Thai process is characterized by standardized operations and high-efficiency turnaround, with a compact cycle and transparent process, suitable for those needing PGT screening but with a limited budget.
- Initial Consultation (Week 1): Can be remote or in-clinic, basic tests include AMH, AFC, hormone panel, semen analysis, infectious diseases, thalassemia screening (Thailand is a high-prevalence area for thalassemia, routine screening).
- Filing: Passport + marriage certificate (some clinics require translation and notarization), quick process.
- Ovarian Stimulation (Week 2–5): Primarily antagonist protocol, moderate dose, stimulation 10–12 days. Monitoring frequency about 4–5 times.
- Egg Retrieval (Week 5): General anesthesia or IV sedation, post-operative observation 2–4 hours.
- Embryo Culture and PGT (Week 5–7): Blastocyst culture + PGT-A (cost approximately $1,500–$2,500). PGT lab certification levels in Thailand vary; it is recommended to choose labs with CAP or JCI certification.
- Transfer (Week 6–8): Primarily frozen embryo transfer, endometrial preparation cycle about 10–14 days. Blood test 10–12 days after transfer.
🔍 What to Watch Out For: Thai law prohibits sex selection, but PGT-A can inform about embryo chromosomal ploidy without disclosing sex. Some clinics have “hidden fees,” such as annual embryo freezing fees, and PGT biopsy fees not included in the cycle cost. Confirm the fee schedule before signing the contract.
🇷🇺 Russia Process: Flexible, Efficient, Lenient Laws
The Russian process has advantages in flexibility of ovarian stimulation protocols and legal tolerance, with clear legal support for egg donation, sperm donation, and surrogacy (not applicable in all states/regions), and high process efficiency.
- Initial Consultation (Week 1): Basic examination package, usually includes AMH, AFC, hormone panel, semen analysis, infectious diseases, thyroid function. Some clinics require hysteroscopy.
- Filing: Passport + health insurance (if applicable). Simple process.
- Ovarian Stimulation (Week 2–5): Antagonist or short protocol, dose adjusted based on age and AMH, stimulation 11–13 days. Monitoring frequency about 4–6 times.
- Egg Retrieval (Week 5): General anesthesia or IV sedation, post-operative observation 1–2 days (some clinics require an overnight stay).
- Embryo Culture and PGT (Week 5–7): Blastocyst culture + PGT-A (optional, cost approximately $1,000–$2,000). Russian PGT labs are of high quality, and attitudes toward embryo gene editing are more lenient than in most countries.
- Transfer (Week 6–8): Frozen or fresh transfer, endometrial preparation cycle about 12–16 days.
🔍 Special Case Handling: Russia has more lenient policies for HIV-positive patients undergoing IVF treatment compared to most other countries, with some clinics having dedicated HIV-positive cycle protocols. However, it is necessary to confirm in advance whether the lab has the appropriate qualifications.
Driving Factors Behind Process Differences
All being IVF, why are the processes so different? The key lies in three aspects:
- Regulation and Law: No federal restrictions in the US, with states regulating individually; Japan is bound by the Japan Society of Obstetrics and Gynecology guidelines, with strict PGT indications; Thailand and Russia have relatively clear laws, but policies are subject to change.
- Insurance and Payment: Most US states lack fertility insurance coverage, with a high proportion of out-of-pocket payments; clinics tend to offer “all-inclusive” pricing, with highly integrated processes. Japan’s National Health Insurance covers some basic tests and medications, with low out-of-pocket costs; clinics tend to simplify and bill in segments. Thailand and Russia are primarily self-pay, with greater variation in fee transparency and supporting services.
- Patient Population Characteristics: The average age of US patients is relatively low (mainly under 35), with good response to stimulation, suitable for high-dose protocols. The average age of Japanese patients is relatively high (over 40 is common), with declining ovarian reserve; mild stimulation is more physiologically appropriate. Patient populations in Thailand and Russia are internationally diverse, leading clinics to design processes emphasizing standardization and reproducibility.
Frequently Asked Questions
Q: Can I still do overseas IVF with low AMH? What is different in the process?
Yes, but you need to choose a process suitable for low reserve. The Japanese mild stimulation protocol is specifically designed for AMH < 1.0, accumulating embryos through multiple retrievals. Some US clinics directly recommend egg donation for AMH < 0.5. Thailand and Russia are more accepting of low AMH patients, but it is advisable to inform in advance to choose an antagonist + growth hormone pretreatment protocol.
Q: How far in advance should I prepare for overseas IVF?
At least 3–6 months in advance. This includes: basic tests (AMH, chromosomes, infectious diseases, etc., results in about 2–4 weeks), visa processing (some countries require 1–2 months), appointment scheduling (popular clinics may require 1–3 months wait), and pre-treatment conditioning (CoQ10, vitamin D, folic acid, etc., recommended at least 2–3 months).
Q: What are the passport validity requirements for overseas IVF?
Passport validity must cover the entire cycle, and it is recommended to have at least 6 months of validity remaining. Some countries (e.g., Russia) require the visa validity to match the treatment period; too short a validity may prevent completion of follow-up visits.
Q: Does the male partner have to accompany the entire process?
Not necessarily. The male partner can provide a semen sample on the day of egg retrieval or 1–2 days in advance for freezing. However, it is recommended that the male partner at least attend the initial consultation and transfer day (if documents need signing). Some countries (e.g., Japan) have more relaxed requirements regarding the male partner’s presence and may accept frozen semen.
Special Situations and Process Adjustments
The following situations will lead to substantial process adjustments:
- Recurrent Implantation Failure (RIF): It is recommended to complete hysteroscopy, endometrial microbiome testing (EMMA/ALICE), and immune screening (NK cells, antiphospholipid antibodies, etc.) before the next cycle. Some US clinics will additionally perform ERA endometrial receptivity testing.
- Poor Ovarian Response (POR): Japanese mild stimulation + multiple egg retrievals for embryo accumulation is the mainstream strategy; the US may switch to high-dose stimulation + growth hormone addition; Thailand and Russia tend towards antagonist + letrozole combination protocols.
- Genetic Disease Carrier: Must choose a country that allows PGT-M (the US, Thailand, and Russia all permit it), and probe preparation is required in advance, taking 2–4 months, so extra time must be allocated.
- Uterine Abnormalities (adenomyosis, polyps, adhesions): Surgical correction or medication pretreatment (GnRH-a for 2–3 months) is needed before transfer, extending the process by 1–3 months.
Process Selection Tendencies by Age Group
| Age Range | Typical Ovarian Reserve Status | More Suitable Country Process | Process Adjustment Suggestions |
|---|---|---|---|
| < 35 years | AMH > 2.5, AFC > 12 | USA / Thailand / Russia | Standard antagonist protocol, consider PGT-A, single blastocyst transfer |
| 35–38 years | AMH 1.5–2.5, AFC 8–12 | USA / Thailand / Japan | Moderate dose stimulation, recommend PGT-A, start CoQ10 supplementation 3 months in advance |
| 39–42 years | AMH 0.8–1.5, AFC 5–8 | Japan / Thailand / Russia | Low dose or mild stimulation, may need multiple retrievals for accumulation, PGT-A as needed |
| > 42 years | AMH < 0.8, AFC < 5 | Japan (mild stimulation) or consider egg donation | Mild stimulation + multiple accumulations, or directly switch to egg donation process; high-dose stimulation not recommended |
📌 Practitioner Observation (Reproductive Medicine Content Editor): A notable change in the last two years is that more and more patients over 35 are proactively requesting PGT-A, but many are unaware that PGT-A can eliminate some “self-correcting” mosaic embryos. In terms of process choice, US clinics generally inform about the transfer possibility of mosaic embryos, but some clinics in Thailand and Russia may directly discard mosaic embryos. This must be clarified before signing the contract.
Doctor’s Advice: How to Choose a Process Based on Your Situation
⚠️ Risk Reminder: The choice of an overseas IVF process should not be based solely on the country, but on the specific clinic, lab certification, and the doctor’s experience with particular ages and ovarian reserves. Within the same country, the process details between different clinics may vary more than the differences between countries. It is recommended that after selecting a country, compare the complete process plans of at least 2–3 clinics, focusing on the ovarian stimulation protocol choice, PGT submission strategy, and embryo freezing policy.
From a real decision-making path, the following four steps can help narrow down the options:
- Clarify core needs: Age, AMH, previous IVF history, need for PGT-M/PGT-A, budget range, and legal tolerance (e.g., acceptance of egg donation/surrogacy).
- Match country process characteristics: Low reserve → Japanese mild stimulation; High reserve + PGT need → USA or Thailand; Limited budget + standardized process → Russia or Thailand; Advanced age + multiple failures → Japan or USA (depending on budget).
- Verify clinic real data: Request the clinic to provide the latest live birth rates stratified by age and AMH, rather than overall averages. Also confirm whether the lab holds CAP, JCI, or ISO15189 certification.
- Build process flexibility: Regardless of the country chosen, reserve at least 2 weeks of buffer time to handle unexpected situations such as abnormal stimulation response, PGT report delays, or insufficient endometrial preparation.
This content is compiled based on public knowledge in the assisted reproduction field and clinical practice, and does not serve as personal medical advice. Please consult a licensed reproductive specialist for specific treatment plans.
Comments (0)